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cense.Abstract Background: Several clinical studies showed that sonoelastography was useful for differ-
entiation of benign and malignant breast lesions. Contrast-enhanced MRI has emerged as a prom-
ising tool in the detection, diagnosis, and staging of breast cancer.
Aim of work: To study the role of sonoelastography versus dynamic MRI in evaluating BI-RADS
III, IV breast masses and detect which modality is of better sensitivity and speciﬁcity trying to guide
the patient either to follow-up the lesion or proceed to lesion excision.
Subjects and methods: The study included 50 Egyptian patients (ages ranged from 32 to 58 years)
who presented by breast masses categorized as BI-RADS III, IV by mammography and ultrasound.
Sonoelastography and dynamic MRI were done for all the patients.
Results: Differentiation between BI-RADS III and IV by US elastography had 84% sensitivity and
84% speciﬁcity and MRI had 88% sensitivity and 80% speciﬁcity.
Conclusion: Regarding the sonoelastography, it is an easy cheap modality. The elasticity score is an
important parameter for lesion characterization. Combination of morphologic and dynamic MRIokki Street, Giza, Egypt. Tel.:
l.com, nohashaﬁ@yahoo.com
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294 N.A. ElSaid, H.G.E. Mohamedstudies is very important for breast lesion evaluation. MRI is more sensitive but less speciﬁc than
sonoelastography. Finally if we ﬁnd any suspicious character elicited by either sonoelastography
or MRI (BI-RADS IV), lesion excision is recommended.
 2012 Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier B.V.
Open access under CC BY-NC-ND license.1. Introduction
Breast masses have a variety of etiologies, benign and malig-
nant. Fibroadenoma is the most common benign breast mass;
invasive ductal carcinoma is the most common malignancy (1).
However most breast masses are benign, breast cancer is the
most common cancer and the second leading cause of cancer
deaths in women [2].
Ultrasonography can effectively distinguish solid masses
from cysts, which account for approximately 25% of breast le-
sions also it differentiate benign from malignant lesions if their
criteria of diagnosis are fulﬁlled [3].
Magnetic resonance imaging (MRI) is being studied to
determine its usefulness in breast masses. Gadolinium contrast
is used to enhance the vascularity of malignant lesions.
Although MRI is highly sensitive (85–100%), it lacks speciﬁc-
ity (47–67%) [4].
It is becoming increasingly clear that while most investiga-
tors have used either enhancement kinetics or lesion morphol-
ogy in an attempt to differentiate benign from malignant
lesions identiﬁed on contrast-enhanced MR imaging studies,
the integration of both kinetic and morphologic information
may ultimately be needed to achieve optimal discrimination [5].
Kuhl et al. [5] described such an integration of kinetics and
architecture as it is used in their practice. The authors make
the very important point that there must be concordance be-
tween the kinetic information and the morphologic features.
There may be malignant lesions, such as certain invasive
ductal and lobular carcinomas and certain ductal carcinoma
in situ lesions that will not enhance rapidly but in which lesion
morphology (i.e., architectural distortion, mass with specu-
lated borders, or ductal enhancement) suggests the presence
of malignancy [5,6].
Sonoelastography is an imaging modality that can quanti-
tatively measure tissue elasticity with the use of sonography
[7].
Several clinical studies showed that sonoelastography was
useful for differentiation benign and malignant breast lesions,
with sensitivity of 78.0–100% and speciﬁcity of 91.0–98.5%. A
discrepancy in lesion sizes between the use of B-mode sonogra-
phy and sonoelastography was a key factor for the diagnostic
criteria in several studies [8–10].
Real-time tissue elastography may provide additional char-
acterization of breast lesions, improving speciﬁcity, particu-
larly for low-suspicion lesions [11].
2. Methodology
2.1. Patients
All the patients were subjected for conventional digital mam-
mographic examination.
Real-time freehand US elastography was performed in 50
consecutivewomenwhounderwent evaluation for breast lesionsat theNational Cancer Institute, CairoUniversity between Feb-
ruary 2009 and June 2010. The lesions were detected at conven-
tional B-mode US and were classiﬁed as category III, IV lesions
according to the Breast Imaging Recording and Data System
(BI-RADS) criteria for US [12]. Lesions were deﬁned as areas
in the breast tissue that were hypoechoic or isoechoic (compared
with the subcutaneous fat) on B-mode images and included both
mass-forming lesions andnon-mass-forming lesions.AtB-mode
imaging, lesions thatwere clearly cystic or those that appeared as
fat islands were not included.
MR mammographic study was done for the patients and
evaluated by two radiologists in consensus and blinded to his-
tological diagnosis.
The lesions were morphologically assessed as regards its
intensity and deﬁnition and presence or absence of lymph
nodes. The lesions were also dynamically assessed and time
intensity curves were done to assess the pattern of contrast up-
take and washout.
2.2. Equipments
Conventional US was performed by using an annular-array
mechanical sector scanner with a frequency of 7.5 MHz (Hit-
achi Medical Systems). All elasticity images were obtained
with a system that consisted of a digital US scanner (EUB-
6500; Hitachi Medical, Tokyo, Japan). The US probe was a
7.5-MHz liner electronic probe (EUP-L53; Hitachi Medical).
None of the patients in this study experienced adverse events
from either conventional US or elastography.
MRI examinations were obtained on a superconducting
1.5 T, MR unit (Signa Horizon, GEMedical Systems, Milwau-
kee, Wisconsin, USA). The following sequences were obtained
and reviewed: T1, T2, fat saturation and dynamic post contrast
study using gadopentetate dimeglumine (Magnevist; Nihon
Schering, Osaka, Japan) or gadodiamide hydrate (Omniscan;
Daiichi Pharmaceutical Co., Tokyo, Japan). Multiple dynamic
and a subtraction sequences were taken then a time intensity
curves were done.
The parameters for TIWIs were a repetition time of 400–
620 ms, echo time of 20–40 ms (400–620/20–40), while the
parameters for T2WIs were 2000–4000/80–120. Slice thickness
of 4–5 mm, interval of 0.8–1 mm and matrix of 256 · 192 were
used. The ﬁeld of view was 160–320 mm.
2.3. Imaging methods
2.3.1. Conventional US
First, conventional US images of the breast were obtained.
During our conventional examination, we obtained B-mode
images. Lesion size was deﬁned as the diameter of the hypo-
echoic lesion at B-mode US.
Lesions were assigned as BI-RADS III or IV
The BI-RADS category of each lesion was determined by
the radiologists with knowledge of the results of physical
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ﬁnal pathologic diagnosis.
2.3.2. Elastography
On the same day, we next obtained elasticity images under
supervision of two experienced radiologists, with the patient
in the supine position oriented perpendicular to the chest wall.
The probe was applied to the breast and was moved slightly
inferior and superior to obtain the elasticity images.
Importantly, to obtain images that were appropriate for
analysis, we applied the probe with only light pressure, which
we deﬁned as a level of pressure that maintained contact with
the skin and permitted imaging conditions for which the associ-
ation between pressure and strain was essentially proportional.
In terms of the region of interest (ROI) used for obtaining
elasticity images, we set the top of the ROI to include subcuta-
neous fat and the bottom of the ROI to include a pectoral
muscle; lateral borders were set more than 5 mm from the le-
sion’s boundary. The ROI needed to be set to include sufﬁcient
surrounding breast tissue because elasticity in normal breast
tissue is displayed relative to the average strain inside the
ROI which is called the strain ratio.
Each pixel of the elasticity image was assigned one of 256
speciﬁc colors, depending on the magnitude of strain. The scale
ranged from red for components with greatest strain (i.e., soft-
est components) to blue for those with no strain (i.e., hardest
components). Green indicated average strain in the ROI.
To classify elasticity images, we evaluated the color pattern
both in the hypoechoic lesion (i.e., the area that was hypoech-
oic or isoechoic relative to the subcutaneous fat .On the basis
of the overall pattern, we assigned each image an elasticity
score on a ﬁve-point scale. A score of 1 indicated even strain
for the entire hypoechoic lesion (i.e., the entire lesion was
evenly shaded in green). A score of 2 indicated strain in most
of the hypoechoic lesion, with some areas of no strain (i.e., the
hypoechoic lesion had a mosaic pattern of green and blue). A
score of 3 indicated strain at the periphery of the hypoechoicFig. 1 Elasticity scores [quolesion, with sparing of the center of the lesion (i.e., the periph-
eral part of lesion was green, and the central part was blue). A
score of 4 indicated no strain in the entire hypoechoic lesion
(i.e., the entire lesion was blue, but its surrounding area was
not included). A score of 5 indicated no strain in the entire
hypoechoic lesion or in the surrounding area (i.e., both the en-
tire hypoechoic lesion and its surrounding area were blue)
(Fig. 1).
2.3.3. Image interpretation of MRI
Suspicious enhancement as early-phase enhancement (an in-
crease in signal intensity of more than 60%) that was apparent
on the ﬁrst enhanced image after the administration of con-
trast material (1 min) or contrast enhancement with suspicious
morphology (ill-deﬁned borders or irregular contour).
Once an enhancing lesion is identiﬁed, it must then be deter-
mined whether the lesion is suspicious for malignancy or is be-
nign. Two major approaches have been used in an attempt to
differentiate suspicious or malignant lesions from benign le-
sions: enhancement kinetics and architectural feature analysis.
Lesion enhancement rates in the early post contrast period
can serve as a method for differentiating malignant from be-
nign lesions, where most of the malignant lesions enhance
more quickly and strongly than benign lesions.
2.3.4. Pathologic diagnoses
All breast lesions were diagnosed histologically by means of
radical surgery, excisional biopsy, or needle biopsy. The path-
ologic results were correlated with the ultrasonographic and
MRI ﬁndings.
3. Results
Fifty cases were examined and subjected to the previously de-
scribed studies and the results were:
Ages ranged from 32 to 58 years, mean = 43.5 and stan-
dard deviation = 6.643.ted from Itoh et al. (13)].
Table 1 Elastography scores of benign and malignant masses.
Pathology (Golden standard) Total
Benign Malignant
Elastography score
1
Count 4 0 4
% within elastography score 100 0 100
% within pathology (Golden standard test) 16 0 8
Elastography score
2
Count 14 4 18
% within elastography score 77.8 22.2 100.0
% within pathology (Golden standard test) 56 16.0 36.0
Elastography score
3
Count 5 9 14
% within elastography score 35.7 64.3 100.0
% within pathology (Golden standard test) 20.0 36.0 28.0
Elastography score
4
Count 2 12 14
% within elastography score 14.3 85.7 100
% within pathology (Golden standard test) 8 48 28
Total pathology
Count 25 25 50
% within elastography score 50.0 50.0 100.0
% within pathology (Golden standard test) 100.0 100.0 100.0
296 N.A. ElSaid, H.G.E. MohamedForty-six cases presented clinically by lump (92%), three
with nodulations (6%) and pain in one patient (2%).
Eighty percent of the benign lumps in 40 cases were well de-
ﬁned by mammography and 24% of malignant lesions in 12
cases appear well deﬁned.
Regarding the density by mammography, 68% of benign le-
sions in 34 cases and 84% of malignant lesions in 42 cases ap-
pear hyperdense.
By US 92% of lesions in 46 cases were well deﬁned and 8%
in four cases were lobulated . Twenty-four percent of the
malignant lesions in 12 cases were well deﬁned and 76% in
38 cases were partially deﬁned.
By US elastography 88% of lesions in 44 cases were well de-
ﬁned and 12% in six cases were lobulated. Twenty-four per-
cent of the malignant lesions in 12 cases were well deﬁned
and 76% in 38 cases were partially deﬁned.
By US 52% of the benign lesions in 26 cases were hypoech-
oic, 32% was heterogenous in 16 cases, deeply hypoechoic in
four cases (8%) and isoechoic in four cases (8%).
Forty percent of the malignant lesions were hypoechoic (20
cases), deeply hypoechoic (32%) in 16 cases and heterogeneous
(28%) in 14 cases.
Ultrasound elastography was done and elasticity score
graded from 1 to 4. Elastography score 1 was noted in four cases
(8%), score 2 in 18 cases (36%), score 3 in 14 cases (28%) and
score 4 in two cases (4%).
Table 1 and Fig. 2 represent the correlation of elasticity
score to benign and malignant lesions.
The mean sizes of the benign masses assessed by US and
after adding elastography was nearly the same but regarding
the malignant masses, the sizes were signiﬁcantly larger afteradding elastography as it detects the extension beyond the le-
sions within the breast parenchyma (Table 2).
The mean strain ratio of benign masses was 6.9 and for
malignant lesions were 10.5. This means that malignant lesions
are mainly hard and the relative increase in benign masses
strain ratio is explained by relative hardness of certain benign
masses containing ﬁbrous tissue.
Regarding the MRI morphology of the lesion, it was 100%
speciﬁc but with 60% sensitivity. Forty percent of the malig-
nant lesions appear morphologically benign by MRI.
Dynamic study of the MRI was 76% sensitive and 76%
speciﬁc.
This is may be due to that some malignant lesions manifest
benign dynamic curve as well as benign morphologic appear-
ance like lobular carcinoma and some benign lesions appear
also vascular giving this low sensitivity and speciﬁcity.
The combination of morphologic and dynamic MRI study
is important.
Differentiation between BI-RADS III and IV by US elas-
tography was 84% sensitive and 84% speciﬁc and MRI had
88% sensitivity and 80% speciﬁcity (Fig. 3).
4. Discussion
4.1. Elastography
From a diagnostic point of view, Itoh et al.’s ﬁndings concur
with those of other studies – namely, that elastography is use-
ful for characterizing breast lesions in general and has the po-
tential to allow differentiation between malignant and benign
lesions [13,14].
Fig. 2 The elasticity scores and its correlation to benign and
malignant lesions.
Table 2 Lesion sizes by conventional US and US
elastography.
Group statistics
Pathology (Golden) N Mean Std. deviation
Mass by ultrasonography
Benign 25 3.2220 2.52117
Malignant 25 5.0376 4.67974
Mass by elastography
Benign 25 3.2892 2.51266
Malignant 25 5.7004 5.26463
Fig. 3 The sensitivity and speciﬁcity of both US elastography
and MRI.
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[standard deviation]; range, 6–30 mm) was determined to be
signiﬁcantly greater than that of benign lesions (mean,
12.6 mm± 6.2; range, 4–30 mm) [13].
In our study the mean diameter of the benign lesions = 33
mm± 25 mm standard deviation both by conventional US
and elastography. The mean malignant lesion diameter = 50
mm± 47 standard deviation by conventional US and
57 mm± 53 mm standard deviation by adding elastography
as elastography detects peripheral extension beyond the lesion
(Table 2).
Cho et al. study results showed that there was a signiﬁcant
difference in the mean strain indices between non palpable
benign and malignant breast masses: 2.63 ± 4.57 (range,0.54–38.76) for benign masses versus 6.57 ± 6.62 (range,
1.29–28.69) for malignant masses (P= .019). A strain index
cutoff value of 2.24 enabled the best distinction between be-
nign and malignant masses [15].
In our study the strain indices were higher (6.9 ± 8.9 stan-
dard deviation for benign masses and 10.5 ± 6.4 standard
deviation for malignant lesions).
In Itoh et al. [13] study, they believed that an elasticity score
of 1, which shows even strain in the entire hypoechoic lesion at
B-mode US, indicates that lesions have almost the same com-
pressibility as the surrounding breast tissue.
In our study, no malignant lesions had a score of 1, this
result suggests that invasive diagnostic procedures, such as
histologic examination, may be omitted for patients who have
lesions with a score of 1.
The elasticity scores of 2, for which parts of the hypoechoic
lesion did not show strain at B-mode US, indicate lesions that
are soft yet somewhat harder than normal breast tissue. This is
often characteristic of lesions such as ﬁbroadenoma or ANDI
(abbreviations in the normal development and involution of
the breast) which is the term describing most of benign breast
diseases [13].
Of the malignant lesions, 84% had ES of 5 and 4, whereas
76% of benign lesions had ES of 1 and 2 [11].
In our study no malignant lesions show elastography score
1, 72% of benign lesions showed elastography score 1 and 2
and 84% of malignant lesions present elastography score 3
and 4 (Table 1 and Fig. 2).
In Itoh et al. [13] study, an elasticity score of 3, which indi-
cates strain at the periphery of the hypoechoic lesion, was
mainly found in benign lesions, including intraductal papillo-
mas. The importance of strain at the periphery is unclear at
present and requires further investigation. We recommend that
all lesions with elasticity scores of 3 or higher be examined by
means of aspiration cytology or needle biopsy because two
(13%) of the 15 lesions with a score of 3 were malignant.
In our study 9 (64.3%) out of 14 cases that show elastogra-
phy score 3 were malignant and 12 (85.7%) out of 14 elastog-
raphy score 4 were malignant (Table 1 and Fig. 2).
The sensitivity and speciﬁcity of elastography were 83.3%
(20 of 24), 86.7% (26 of 30) [13].
In our study sensitivity and speciﬁcity of elastography was
84% (21 of 25) for both (Fig. 3) which is near to the previously
mentioned results.
4.2. MRI
4.2.1. Enhancement kinetics or lesion morphology: which is best?
While the focus of the article by Kuhl et al. (5) is the evaluation
of enhancement kinetics as a method for differentiating benign
from malignant lesions, the authors make a very important
point that the analysis of lesion enhancement kinetics should
not be used as a stand-alone criterion for lesion diagnosis,
but rather should be evaluated along with lesion morphology.
Architectural features suggesting benign disease include a
mass with smooth or lobulated borders, a mass demonstrating
no contrast enhancement, a mass with nonenhancing internal
septations, and patchy parenchymal enhancement (6,16).
Contrast-enhanced MRI has emerged as a promising tool
in the detection, diagnosis, and staging of breast cancer.
The speciﬁc imaging and diagnostic evaluation protocols
are varied. Most centers rely on a combination of lesion
Fig. 4 Thirty-seven-year-old female presented by left breast lump. Real-time ultrasound and sonoelastography (A) on the right a
relatively hypoechoic well deﬁned mass showing elasticity score 2 (mosaic appearance) and low strain ratio on left side (BI-RADS III).
(B & C) MR study and dynamic curve showing mild contrast uptake of a well deﬁned lesion with a curve showing rising benign pattern.
Pathology was ﬁbroadenoma.
Fig. 5 Forty-year-old female presented by right breast lump. Real-time ultrasound and sonoelastography (A) on the right a relatively
hypoechoic lobulated mass showing elasticity score 2 (mosaic appearance) and low strain ratio on the left side (BI-RADS III). (B & C)
MR study and dynamic curve showing contrast uptake of a well deﬁned lesion with a curve showing washout pattern. Pathology was
ﬁbroadenoma with atypical cells.
298 N.A. ElSaid, H.G.E. Mohamedmorphology (high-spatial resolution) and enhancement pat-
tern (high temporal resolution or dynamic imaging during
the contrast injection) when diagnosing breast MRI. As a re-
sult of this methodic variation, the published sensitivity and
speciﬁcity values of breast MRI range between 80% and
98%, respectively (17,18).
In our study regarding MRI morphology, it was 100% spe-
ciﬁc and 60% sensitive, regarding dynamic study, both sensi-
tivity and speciﬁcity were 76% and by combining both
kinetics and morphology, speciﬁcity was 80% and sensitivity
was 88% (Fig. 3).
When a type I curve is identiﬁed, this can be used to sup-
port the diagnosis of a benign or probably benign lesion, avert-
ing performance of biopsy (5). This was going with a
ﬁbroadenoma case presented in Fig. 4.
One of our presented cases showed benign features by elas-
tography and MRI morphology with washout dynamic curve
(Fig. 5) and pathology detected ﬁbroadenoma with atypical
cells.
In their breast MR imaging practice, Kuhl et al. (5) ana-
lyzed the time course kinetics only after evaluating lesion mor-
phology on postcontrast images. In those cases in which the
morphology suggests malignancy, the kinetic information is
not evaluated. When the morphology is indeterminate or sug-
gests a benign lesion, the authors recommend performing a
time–signal intensity curve analysis. When the morphologysuggests a benign or indeterminate lesion but a plateau curve
is detected, the authors recommend performing biopsy; this
was similar to the case presented in Fig. 6.
Several investigators (4,6) have reported architectural fea-
tures identiﬁed on high-spatial resolution, contrast-enhanced
MR imaging studies that can be used for lesion diagnosis.
Architectural features that suggest the possibility of malig-
nancy include a mass with irregular or speculated borders, a
mass with peripheral enhancement, and ductal enhancement.
One of our presented cases (Fig. 7) showed a well deﬁned
lesion by ultrasound and MRI not presenting with previously
described typical MRI manifestations of malignancy, however
its elasticity score was 4 and the lesion showed mild washout
curve by dynamic MRI study. The pathology was invasive
duct carcinoma.
Another case showed morphologically benign features by
elastography and MRI with high strain ratio and washout
MRI dynamic curve. Lesion excision was recommended and
unexpectedly the pathology was ﬁbroadenoma (Fig. 8).
There may be malignant lesions, such as certain invasive
ductal and lobular carcinomas and certain ductal carcinoma
in situ lesions that will not enhance rapidly and show benign
kinetics in which the lesion morphology (i.e., architectural dis-
tortion, mass with speculated borders, or ductal enhancement)
suggests the presence of malignancy (4,5). This was similar to
what was presented in Fig. 9.
Fig. 6 Forty-six-year-old female presenting by bilateral breast nodularity. Real-time ultrasound and sonoelastography (A) on the right a
relatively hypoechoic rather well deﬁned left breast mass showing elasticity score 1 and low strain ratio (BI-RADS III) (left side of the
image). (B) MR study and dynamic curve showing mild contrast uptake of a well deﬁned lesion with a curve showing rising benign pattern
(BI-RADS III) (C). Another dynamic study of a right breast lesion for the same patient showing plateau curve (BI-RADS IV) (D).
Pathology was multiple papillomatosis.
Fig. 7 Thirty-seven-year-old female presenting by right breast lump. Real-time ultrasound and sonoelastography (A) on the right a
rather well deﬁned hypoechoic right breast mass showing elasticity score 4 and high strain ratio on the left of the image (BI-RADS IV).
MR study and dynamic curve showing contrast uptake of a well deﬁned lesion (left side of B). On the right side a curve shows mild
washout appearance (BI-RADS IV) (B). Pathology was invasive ductal carcinoma.
Fig. 8 Forty-four-year-old female presented by right breast lump. Real-time ultrasound and sonoelastography (A) on the right a
hypoechoic well deﬁned mass showing elasticity score 2 (mosaic appearance) and high strain ratio on the left (BI-RADS IV) (B). MR
study and dynamic curve showing contrast uptake of a well deﬁned lesion with a suspicious curve showing washout pattern (C). Pathology
was ﬁbroadenoma.
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Fig. 9 Fifty-three-year-old female presented by right breast lump. Real-time ultrasound and sonoelastography (A) on the right a
relatively hypoechoic partially lobulated mass showing elasticity score 5 and high strain ratio on the left (BI-RADS IV). MR study and
dynamic curve showing contrast uptake of a lobulated lesion with a curve showing rising benign pattern (B). Pathology was invasive
lobular carcinoma.
300 N.A. ElSaid, H.G.E. Mohamed5. Conclusion
 Both ultrasound and MRI are useful for breast lesion char-
acterization but sonoelastography is an easier and cheaper
method and more speciﬁc than MRI but it is operator
dependent.
 Elasticity score is a very good parameter in lesion character-
ization followed by measuring the strain ratio of the lesion.
 When we shift to MRI for more assessment we must com-
bine both morphologic and dynamic studies. MRI is useful
in detecting the multiplicity of lesions and detection of early
ductal enhancement in in situ lesions.
 If one of the previously mentioned parameters was suspi-
cious, lesion excision is recommended.Acknowledgments
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